Wells Fargo Initiates Coverage of CME Group at Overweight
Fintel reports that on October 2, 2026, Wells Fargo initiated coverage of CME Group (NASDAQGS:CME) (BMV:CME) with a Overweight recommendation. Prior to this rating action, the stock closed at $265.10 on October 1, 2026, and subsequently finished the next session at $263.03 on October 2, 2026.
CME Group Inc., based in the United States, operates as a global leader in the derivatives marketplace, offering a wide array of financial instruments, including futures and options. Primarily functioning in the financial industry, CME Group provides platforms for trading of commodities, equities, foreign exchange, interest rates, and other derivatives. Key projects of the company typically focus on expanding its products and technological innovations to enhance trading efficiency and security. For instance, they frequently update their trading infrastructure and have expanded their offerings to include digital asset futures, aimed at integrating blockchain technologies within traditional financial markets.
The company's stock has experienced recent price fluctuations. On September 25, 2026, the baseline close was $264.48, representing a price change of -0.55% over one week leading to the latest close of $263.03 on October 2, 2026. Looking back further, the one-month baseline close was $277.77 on September 2, 2026, which reflects a price change of -5.31% over that period. In other analyst activities, TD Cowen reiterated its Buy rating on September 28, 2026, after previously reiterating its Buy rating on September 3, 2026.
Separately from Wells Fargo's individual rating, the broader market consensus shows a target price mean of $291.61 and a median of $291.21 as of September 15, 2026. This mean target represents an implied change of +10.86% from previous levels. The prior consensus target mean was $291.02 as of August 28, 2026, indicating a consensus target revision of +0.20%. In terms of aggregate recommendations, as of September 1, 2026, the current recommendation period consisted of 21 total recommendations: 2 strong buy, 9 buy, 7 hold, and 3 sell. This represents 52.4% positive, 33.3% hold, and 14.3% negative recommendations. In the prior period as of August 1, 2026, there were 21 total recommendations, including 2 strong buy, 10 buy, 6 hold, and 3 sell, which represented 57.1% positive, 28.6% hold, and 14.3% negative recommendations.
CME Group last reported its quarterly earnings on July 22, 2026. The company posted an actual EPS of 2.99, compared to an estimate of 2.9375, representing an EPS surprise of +1.79%. Actual revenue reached $1,706,200,000.00, exceeding the estimated revenue of $1,702,277,139.00. The company's upcoming earnings announcement is scheduled for October 21, 2026, during the before market open (bmo) session.
Recent analyst actions
| Date | Analyst | Prior | Latest recommendation | Action |
|---|---|---|---|---|
| October 2, 2026 | Wells Fargo | Overweight | initiated coverage | |
| September 28, 2026 | TD Cowen | Buy | Buy | reiterated |
| September 3, 2026 | TD Cowen | Buy | Buy | reiterated |
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.